3.0.0
5539
2023-10-30T19:01:19Z
2023-10-30T19:01:19Z
House
HR
2021-10-08
117
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2021-10-11T15:14:29Z
  - Referred to
2021-10-08T14:02:10Z
- 2021-10-11
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2021-10-08
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2021-10-08
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2021-10-08
Introduced in House
IntroReferral
1000
9
Library of Congress
- S001145
Rep. Schakowsky, Janice D. [D-IL-9]
JANICE
SCHAKOWSKY
D
IL
D.
9
N
- N000147
Del. Norton, Eleanor Holmes [D-DC-At Large]
ELEANOR
NORTON
D
DC
HOLMES
0
2021-10-22
False
- M001185
Rep. Maloney, Sean Patrick [D-NY-18]
Sean
Maloney
D
NY
Patrick
18
2021-11-03
False
- K000380
Rep. Kildee, Daniel T. [D-MI-5]
Daniel
Kildee
D
MI
T.
5
2021-11-09
False
- T000482
Rep. Trahan, Lori [D-MA-3]
Lori
Trahan
D
MA
3
2021-11-09
False
- G000551
Rep. Grijalva, Raúl M. [D-AZ-3]
Raúl
Grijalva
D
AZ
M.
3
2021-12-02
False
- M001188
Rep. Meng, Grace [D-NY-6]
Grace
Meng
D
NY
6
2022-03-15
False
- G000586
Rep. Garcia, Jesus G. "Chuy" [D-IL-4]
Jesus
Garcia
D
IL
G.
4
2022-04-26
False
- J000298
Rep. Jayapal, Pramila [D-WA-7]
Pramila
Jayapal
D
WA
7
2022-05-10
False
- B001313
Rep. Brown, Shontel M. [D-OH-11]
Shontel
Brown
D
OH
M.
11
2022-09-30
False
Health
- Administrative law and regulatory procedures
- Advisory bodies
- Business records
- Civil actions and liability
- Cosmetics and personal care
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
- Government information and archives
- Hazardous wastes and toxic substances
- Retail and wholesale trades
Health
00
2021-10-08
Introduced in House
2022-07-19T17:25:10Z
Cosmetic Supply Chain Transparency Act of 2021
This bill requires the Food and Drug Administration (FDA) to maintain a list of certain nonfunctional constituents in cosmetics that are harmful to human health or the environment, authorizes the FDA to request from a brand owner (i.e., the entity bringing a cosmetic to market) certain information about a cosmetic's ingredients, and addresses related issues.
For each listed nonfunctional constituent, the list must identify the ingredient or cosmetic (or category of ingredient or cosmetic) in which the constituent is known or reasonably expected to be present. The FDA must also (1) establish procedures for petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance.
Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request.
Brand owners must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request.
The bill also imposes civil penalties for brand owners and suppliers that violate this bill's provisions.

Cosmetic Supply Chain Transparency Act of 2021
- Official Title as Introduced

To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.
Introduced in House
IH
- Display Title

Cosmetic Supply Chain Transparency Act of 2021
- Short Title(s) as Introduced

Cosmetic Supply Chain Transparency Act of 2021
Introduced in House
IH
- Introduced in House
2021-10-08T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-117hr5539ih/xml/BILLS-117hr5539ih.xml
2021-10-11
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.